A new clinical trial at The Ohio State University is aiming to shorten the recovery period of motor skills for stroke patients via vagus nerve stimulation (VNS), drastically improving patients’ post-stroke outcomes and quality of life. Vivistim, a device developed by the Dallas-based company MicroTransponder, works by pairing VNS with muscle movement during rehabilitation. The pairing leads to strengthening of the neural circuits in the brain associated with motor function, learning, and memory.

As one of the leading causes of disability worldwide, acute ischemic stroke (AIS) is becoming increasingly prevalent due to both the growing aging population and an increase in risk factors such as high blood pressure, diabetes, high cholesterol, and obesity. Stroke, particularly in older adults, can lead to loss of motor function in multiple areas, such as movement, balance, and coordination; however, early treatment has been shown to reduce the chances of poor post-stroke outcome.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

With the rising rate of stroke, focus has been placed on improving the prevention, intervention, and rehabilitation stages of stroke care. Neurovascular thrombectomy is positioned to be the new gold standard of treatment for stroke, as studies have shown that patients who received thrombectomy were “more likely to be functionally independent than those who received tPA [tissue plasminogen activator] alone” (Kulkarni, 2015). GlobalData expects the number of thrombectomy procedures to grow to 100,000 by 2027, which would lead to a decrease in post-stroke disability. Utilizing nerve stimulation for rehabilitation in combination with effective interventions would limit the impact of complications following an event.

The new application of nerve stimulation within stroke care could drastically improve the quality of life and recovery for stroke patients. If the Vivistim shows positive results in stroke patients regaining motor function earlier, many doors for potential rehabilitative treatment and reducing the burden of stroke on healthcare systems could be opened for the device.

For more insight and data, visit the GlobalData Report Store – Medical Device Network is part of GlobalData Plc.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.